Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Link opens in a new tab
Search content at Illinois Experts
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Nano drug delivery systems in upper gastrointestinal cancer therapy
Julia Salapa
, Allison Bushman
, Kevin Lowe
,
Joseph Irudayaraj
Bioengineering
Materials Science and Engineering
Micro and Nanotechnology Lab
Biomedical and Translational Sciences
Food Science and Human Nutrition
Carl R. Woese Institute for Genomic Biology
Beckman Institute for Advanced Science and Technology
Office of the Vice Chancellor for Research and Innovation
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nano drug delivery systems in upper gastrointestinal cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Therapy
100%
Nano-drug Delivery System
100%
Upper Gastrointestinal Cancer
100%
Gastrointestinal Carcinoma
100%
Nanoparticles
40%
Upper Gastrointestinal Tract
40%
Nanomedicine
20%
Strategic Use
20%
Motivation
20%
Delivery System
20%
Nanoparticle Systems
20%
Therapeutic Potential
20%
Diagnostic Tool
20%
Targeted Cancer Therapy
20%
Drug Agents
20%
Recurrence Rate
20%
Cancer Types
20%
Systemic Side Effects
20%
Cancer Theranostics
20%
Standard of Care
20%
Therapeutic Tool
20%
High Toxicity
20%
Gastrointestinal Cancer
20%
Late Diagnosis
20%
Nanoparticle Drug Delivery
20%
Systemic Therapy
20%
Drug Formulation
20%
Metastasis Formation
20%
Early Metastasis
20%
Drug Delivery Formulations
20%
Cancer Medication
20%
Medicine and Dentistry
Cancer Therapy
100%
Drug Delivery System
100%
Upper Gastrointestinal Cancer
100%
Gastrointestinal Carcinoma
100%
Nanoparticle
100%
Nanomedicine
20%
Metastatic Carcinoma
20%
Malignant Neoplasm
20%
Cancer
20%
Early Diagnosis
20%
Recurrence Risk
20%
Side Effect
20%
Cancer Types
20%
Systemic Therapy
20%
Gastrointestinal Cancer
20%
Molecularly Targeted Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Delivery System
100%
Nanoparticle
100%
Digestive System Cancer
100%
Malignant Neoplasm
60%
Side Effect
20%
Nanomedicine
20%
Recurrence Risk
20%
Drug Formulation
20%